ZETROZ SYSTEMS LLC
Trumbull, CT · Medtech · Private
Wireless long-duration low-intensity ultrasound sonophoresis device with NSAID enhancement for transdermal drug delivery in osteoarthritis pain management
- Grants
- $19M
- 19 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $1000K
- 1 award · Defense
- #319 of 4531 in medtech
- Patents
- 13
- 2 granted · 11 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Defense · Phase I · Hydrogel-based Long-duration ultrasound wound dressing to enhance cellular regeneration and rapid wound closure | $149,997 | |
| Federal grant | Department of Health and Human Services · Phase II · Self Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations | $1,200,000 | |
| Federal contract | Department of Defense · Igf::ot::igf. Dhp Phase II STTR Entitled "innovative Wound Regeneration Support Approaches To Enable Rapid Treatment Of Wounded Warfighters". | $999,979 | |
| Federal grant | Department of Health and Human Services · Phase II · Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations | $268,958 | |
| Federal grant | Department of Health and Human Services · Phase II · Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations | $400,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Self-Applied Wearable Ultrasound Therapy for Osteoarthritis Management in Underserved Populations | $400,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis | $224,176 | |
| Federal grant | Department of Health and Human Services · Phase I · Daily and localized NSAID sonophoresis for symptomatic treatment of knee osteoarthritis | $223,719 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain | $217,772 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain | $451,369 | |
| Federal grant | Department of Health and Human Services · Phase II · Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $1,442,543 | |
| Federal grant | Department of Health and Human Services · Phase II · Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $1,427,916 | |
| Federal grant | Department of Health and Human Services · Phase I · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain | $233,597 | |
| Federal grant | Department of Health and Human Services · Phase II · Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $1,438,616 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain | $1,482,405 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain | $1,482,405 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical Optimization of Ultrasonic Drug Delivery Technologies for Underserved Minority US Veterans in Chronic Pain | $1,578,495 | |
| Federal grant | Department of Health and Human Services · Phase II · Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $2,196,474 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical Optimization of Ultrasonic Drug Delivery Technologies for US Veteran Populations that Experience Health Disparities with Arthritis and Chronic Pain | $1,457,643 | |
| Federal grant | Department of Health and Human Services · Phase II · Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis | $2,359,304 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 316 | inNOveta Biomedical LLC | $1.0M | — |
| 317 | Carrera Bioscience Inc. | $1.0M | — |
| 318 | BIOWAVE CORP | $1.0M | $1.7M |
| 319 | ZETROZ SYSTEMS LLC | $1000K | — |
| 320 | Caregility Corp | $997K | $7.5M |
| 321 | ARETE BIOSCIENCES | $995K | — |
| 322 | CROSSLIFE TECHNOLOGIES INC. | $966K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- High Density Ultrasound Coupling Gel And Methods Of Use Thereofapplication
- Wireless Ultrasound Devicegranted
- Low-profile, Low-frequency, And Low-impedance Broad-band Ultrasound Transducer And Methods Thereofgranted
- Flexible And Wearable Long Duration Ultrasound Deviceapplication
- Ultrasound Coupling Patch With Gel Capture Featureapplication
- Limited Use Ultrasonic Coupling Deviceapplication
- Ultrasound Coupling Patch With Gel Capture Featureapplication
- Fleixble And Wearable Long Duration Ultrasound Deviceapplication
- Low-profile Ultrasound Transducer With Dose Monitoring And Adaptive Regulationapplication
- Ultrasound Coupling Gel And Patch For Improved Thermal, Drug Delivery And Long Duration Ultrasound Treatmentapplication
- Low-profile Ultrasound Transducer With Dose Monitoring And Adaptive Regulationapplication
- Ultrasound Transducer Arrayapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.